14,344 Shares in Ventas, Inc. $VTR Bought by Focus Partners Advisor Solutions LLC

Focus Partners Advisor Solutions LLC acquired a new position in Ventas, Inc. (NYSE:VTR - Free Report) in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 14,344 shares of the real estate investment trust's stock, valued at approximately $1,274,000.

• Why Welltower's Growth Story Might Outrun Its Rich Valuation

Several other institutional investors have also recently added to or reduced their stakes in the business. Deutsche Bank AG boosted its stake in Ventas by 0.7% in the fourth quarter. Deutsche Bank AG now owns 3,904,293 shares of the real estate investment trust's stock valued at $302,114,000 after acquiring an additional 27,688 shares during the period. Bank of New York Mellon Corp grew its holdings in shares of Ventas by 2.5% during the fourth quarter. Bank of New York Mellon Corp now owns 2,868,962 shares of the real estate investment trust's stock valued at $222,000,000 after purchasing an additional 70,459 shares during the last quarter. Norges Bank bought a new position in shares of Ventas during the fourth quarter valued at approximately $474,571,000. Mitsubishi UFJ Asset Management Co. Ltd. raised its position in shares of Ventas by 7.4% during the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 1,346,111 shares of the real estate investment trust's stock worth $104,095,000 after purchasing an additional 92,236 shares during the period. Finally, Cbre Investment Management Listed Real Assets LLC raised its position in shares of Ventas by 5.8% during the 4th quarter. Cbre Investment Management Listed Real Assets LLC now owns 1,851,968 shares of the real estate investment trust's stock worth $143,305,000 after purchasing an additional 101,370 shares during the period. Institutional investors own 94.18% of the company's stock.

Insiders Place Their Bets

In related news, Director Michael J. Embler acquired 2,500 shares of Ventas stock in a transaction that occurred on Wednesday, June 3rd. The stock was acquired at an average price of $78.81 per share, with a total value of $197,025.00. Following the completion of the acquisition, the director directly owned 19,202 shares of the company's stock, valued at $1,513,309.62. This trade represents a 14.97% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.53% of the stock is owned by insiders.

Analyst Ratings Changes

• 6 largest healthcare REITs to buy and how to invest

VTR has been the topic of several recent research reports. UBS Group raised their price target on Ventas from $85.00 to $93.00 and gave the stock a "neutral" rating in a report on Monday, May 4th. BMO Capital Markets upped their price objective on Ventas from $105.00 to $107.00 and gave the stock an "outperform" rating in a research note on Tuesday, August 11th. The Goldman Sachs Group reaffirmed a "buy" rating and issued a $110.00 target price on shares of Ventas in a research report on Tuesday, May 19th. Barclays initiated coverage on Ventas in a research note on Tuesday, July 7th. They issued an "equal weight" rating and a $99.00 target price on the stock. Finally, Cantor Fitzgerald boosted their price target on shares of Ventas from $97.00 to $102.00 and gave the company an "overweight" rating in a report on Friday, July 31st. Fifteen research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $98.00.

Get Our Latest Report on VTR

Ventas Trading Down 0.0%

• Analysts See Strong Upside Trade for Undervalued REITs

NYSE:VTR opened at $91.48 on Monday. Ventas, Inc. has a 1 year low of $66.38 and a 1 year high of $101.60. The stock has a market cap of $46.92 billion, a price-to-earnings ratio of 169.40, a PEG ratio of 2.11 and a beta of 0.69. The business has a fifty day moving average of $90.45 and a 200-day moving average of $86.61. The company has a debt-to-equity ratio of 0.86, a quick ratio of 0.44 and a current ratio of 0.44.

Ventas Profile

(Free Report)

Ventas, Inc NYSE: VTR is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas' business model combines property ownership with active asset management and capital markets activity.

See Also

• Five stocks we like better than Ventas
• The Metals Company’s Big Bet Now Comes Down to a License
• OneSpaWorld Keeps Turning Cruise Demand Into Record Earnings
• Meta and Tesla Are Rebounding From Oversold Levels—Now What?
• AMG’s Alternatives Boom Powers Record Growth

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Ventas Right Now?

Before you consider Ventas, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ventas wasn't on the list.

While Ventas currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here